LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
  • AstraZeneca PLC (LSE: AZN) Latest News

    Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
    Investing Articles

    I wish I’d known about this profitable stock market investing strategy 10 years ago

    Long-term data suggests this investment approach yields returns that surpass the performance of major stock market indexes.

    Read more »

    Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
    Investing Articles

    2 of my favourite FTSE 100 shares have just plunged 12% and 10%! Time to buy?

    Harvey Jones is in bargain-hunting mode and wondering if these two FTSE 100 shares could make exciting purchases after falling…

    Read more »

    Abstract bull climbing indicators on stock chart
    Investing Articles

    As AstraZeneca’s share price drops 13% should I buy on the dip?

    AstraZeneca’s share price has fallen following unfavourable results for one of its new drugs, but others look good, and earnings…

    Read more »

    Young woman holding up three fingers
    Investing Articles

    3 stunning FTSE 100 shares I plan to buy in October 

    Our writer identifies three stocks on the FTSE 100 he feels would add the variety of growth, income and stability…

    Read more »

    Investing Articles

    This UK stock looks pretty cheap to me

    This Fool is always on the hunt for value, and with plenty of potential for growth, this UK stock ticks…

    Read more »

    Edinburgh Cityscape with fireworks over The Castle and Balmoral Clock Tower
    Investing Articles

    My favourite UK share on the entire LSE has fallen 5% in a week! Time to buy?

    Harvey Jones has waited for years to buy this brilliant UK share. Has the recent stock market dip finally handed…

    Read more »

    Investing Articles

    FTSE 100 investors should pay attention to these 4 things in September 2024

    Charlie Carman explores four key factors for UK investors to monitor this month that will influence the future direction of…

    Read more »

    Investing Articles

    4 stocks that might power the FTSE 100 towards 10,000

    The FTSE 100 has been flirting with its all-time high again. Could it break through and hit that magical 10,000…

    Read more »

    Investing Articles

    As AstraZeneca reaches a 52-week high, is this still a top UK stock to consider?

    Ben McPoland takes a look at the largest UK stock by market cap to assess whether it might be overvalued…

    Read more »

    Silhouette of a bull standing on top of a landscape with the sun setting behind it
    Investing Articles

    5 FTSE stocks Fools think will lead the next bull market charge

    Savvy Fools will know the time to be buying the best FTSE stocks isn’t when a new bull market is…

    Read more »

    Person holding magnifying glass over important document, reading the small print
    Investing Articles

    Up 38% from its 12-month low, how can AstraZeneca’s share price still look cheap?

    Despite its big rise over the year, AstraZeneca’s share price still looks very undervalued to me, supported by strong H1…

    Read more »

    Investing Articles

    AstraZeneca hits £200bn as its share price soars. Can I afford to miss out?

    The AstraZeneca share price is up 17% so far this year. But now the firm has broken the £200bn barrier,…

    Read more »